A comprehensive pan‐cancer proteomic analysis revealed a potential lactylated amino acid site on NSUN2.[40] In addition, molecular docking in the Molecular Operating Environment (MOE) was employed to predict the binding affinity between L‐lactic acid molecules and NSUN2 protein, and the results indicated that two lysine sites were predicted to be potentially lactylated (Figure 5J). The gene discussed is NSUN2; the disease is cancer.